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treptococcus agalactiae also called Group B 
SStreptococcus (GBS) is Gram-positive coccus that is currently the leading infectious agent 
responsible for neonatal morbidity and mortality 
1
in  the United States .  Maternal  vaginal 
colonization by GBS from the gastrointestinal tract 
is the primary risk factor for GBS newborn 
2
diseases . Vertical transmission of GBS from a 
vagina-colonized mother to her newborn upon 
rupture of membrane or after the onset of labour 
can cause life-threatening infections such as 
3
neonatal sepsis and meningitis .
The colonization of the vagina by GBS have been 
shown to be associated with frequency of sexual 
4,5intercourse and multiple sexual partners . This 
colonization can be transient, chronic, or 
intermittent and may affect 10% to 30% of 
6
pregnant women , and usually occurs in late 
adolescence rather than childhood. Women of 
childbearing age carry GBS at variable frequencies 
with similar gures in both developing and 
7developed countries . 
In 1996, the Centres for Disease Control and 
Prevention (CDC) in collaboration with the 
American Col lege  of  Obstetr ic ians  and 
Gynaecologists (ACOG) and the American 
Academy of Paediatrics (AAP) published a 
consensus guideline on the prevention of early-
onset neonatal GBS disease and the use of 
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intrapartum antibiotics in order to prevent vertical 
transmission of GBS. Two preventive strategies 
were described, a risk-based approach (based on 
maternal factors with or without known GBS 
colonization) and a screening-based approach 
(based on a combination of risk factors and GBS 
8
colonization) . The policy statement strategies 
involved universal screening of pregnant women 
for GBS colonization at 35-37 weeks of gestation, 
0or the risk-based approach base on fever ≥38 C 
0
(104.5 F), PROM ≥ 18 hours, ˂ 37 weeks of gestation, 
established GBS colonization were acceptable 
alternatives. Subsequent surveillance studies 
revealed that almost 50% of neonatal GBS EOS 
infections were not identied using the risk-based 
9approach . 
In 2002, CDC, ACOG and AAP reissued their most 
current guidelines to specically promote 
universal screening for GBS at 35-37 weeks and 
treatment of colonized women with intrapartum 
3,8antibiotic prophylaxis (IAP) . To help narrow the 
use of IAP, the guidelines did not recommend that 
women with GBS-negative culture within 5 weeks 
of delivery receive GBS prophylaxis in the 
presence of intrapartum risk factors. In addition, 
new algorithms were also included regarding GBS 
prophylaxis for threatened preterm delivery and 
the management of neonates exposed to 
intrapartum prophylaxis.  This refocused 
approach led to an additional decline in GBS-
related EOS to a reported incidence of 0.3 per 
thousand in term neonates, and one which has 
surpassed the established goals of Healthy People 
2010 of achieving an incidence of 0.5 per 1000 for 
8,10EOS . Concurrently, mortality associated with 
GBS EOS in  term infants  a lso  dropped 
dramatically. Although the initial dramatic 
decrease in the incidence of GBS EOS was 
reective of declines among African-American 
neonates, analysis of more recent data continues to 
reveal a several fold higher incidence of GBS EOS 
9,11,12in African-American versus white infants .
Chemoprophylaxis remains the most effective 
means to prevent maternal and neonatal 
infections. Penicillin, ampicillin, erythromycin 
and clindamycin are drugs of choice for antibiotic 
prophylaxis against GBS. However, GBS resistant 
to erythromycin and clindamycin have been 
reported for many years though these antibiotics 
are used as alternatives for penicillin allergic 
women who need intrapartum antibiotics 
13prophylaxis . Resistance to erythromycin is 
frequently associated with concomitant 
clindamycin resistance in what is called 
macrolides-inducible resistance to clindamycin 
produced by an inducible methylase that alters the 
common ribosomal binding site for macrolides, 
clindamycin and the group B streptogrammins 
14
(quinupristin)  .
Monitoring for new resistance mechanism in GBS 
is important as resistance genes can be spread 
among closely related species such as Enterococcus 
species and Streptococcus pneumonia. Group B 
Streptococcus isolates that were susceptible to 
erythromycin but resistant to clindamycin were 
recently shown to have the linB gene, which was 
previously identied only in Enterococcus 
15
faecium . 
Considering the above documented resistant 
pattern, it is advisable to perform antimicrobial 
susceptibility testing in order to guide the 
selection of appropriate intrapartum antibiotics 
prophylaxis.
This study was aimed at determining the 
a n o g e n i t a l  c o l o n i z a t i o n  a n d  a n t i b i o t i c 
susceptibility of Streptococcus agalactiae isolates 
from women receiving health care at the Jos 
University Teaching Hospital (JUTH).
MATERIALS AND METHODS
Study Area
The study was carried out in Jos University 
Teaching Hospital (JUTH). Jos University 
Teaching Hospital is located in Jos the Plateau 
State capital. The hospital is a tertiary health 
institution with a 600 beds capacity serving 
Plateau State and majority of the states in the 
North-central and part of North-east geopolitical 
zones of Nigeria. Jos University Teaching Hospital 
is also a centre for AIDS Prevention Initiative in 
Nigeria (APIN) that cater for most people leaving 
with HIV (PLHIV) from within and the bordering 
states. The main occupation of the people is 
farming with majority of them in the city being 
civil servants and businessmen and women.
Study Population
The study population included pregnant and non-
pregnant women of childbearing age attending 
ante-natal and gynaecology clinics at Jos 
University Teaching Hospital between July 2017 
and November 2017.
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Study Design
The study was a hospital based descriptive, cross-
sectional study that recruited 300 consenting 
pregnant and non-pregnant women attending 
antenatal and gynaecology clinics at the Jos 
University teaching Hospital.
Ethical Consideration
This study was approved by the research ethical 
committee of Jos University Teaching Hospital 
w i t h  r e f e r e n c e  n u m b e r 
JUTH/DCS/ADM/127/XIX/6583. Written 
informed consents were also signed by all subjects 
before enrollment in the study.
Sample Collection
Anorectal and vaginal swab samples were 
carefully and aseptically collected from 
consenting 200 pregnant and 100 non-pregnant 
women using sterile swab sticks by the attending 
physicians after given them appropriate 
instructions on how the sample should be 
16collected . 
Specimen Transport
The collected specimens were immediately 
inoculated into a selective enrichment broth, Todd 
- Hewitt broth (Oxoid LTD) supplemented with 
gentamycin (8μg/ml), nalidixic acid (15μg/ml) 
and 5% sheep blood to increase the recovery rate of 
16,17
GBS . These were transported to the laboratory 
within three hours of inoculation. 
Culture and Incubation
The inoculated Todd-Hewitt broths were 
O
incubated aerobically at 37 C for 18 to 24 hours. 
After an overnight incubation, the broths were 
subcultured onto 10% sheep blood agar and 
chromatic Strepto B agar (Liolchem, Italy), a 
selective medium for GBS and incubated 
aerobically in 5-10% CO2 (candle extinction jar) at 
O37 C for 18 to 24 hours, while the inoculated 
chromatic Strepto B agar plates were incubated 
O 18
aerobically at 37 C for 18 to 24 hours . The 
Streptococcus agalactiae control strain was also 
inoculated onto 10% sheep blood agar and 
chromatic Strepto B agar and incubated at the 
same conditions stated above. 
Identication of GBS Isolates
Group B Streptococcus isolates were identied by 
their beta haemolytic pattern on 5% sheep blood 
agar and blue-green colour on chromatic Strepto B 
agar. The isolates were further subjected to Gram 
staining, catalase test, and serogrouping using 
streptococcal grouping kit (DR0585A OXOID) 
from Oxoid.
Antibiotics Susceptibility Testing
The GBS isolates were tested for susceptibility to 
penicillin G (10units),  ampicillin (10μg), 
erythromycin (15μg), vancomycin (30μg), 
clindamycin (2μg), and ceftriaxone (30μg) (Oxoid 
Nig. Ltd) using the modied Kirby-Bauer disk 
19,20diffusion method .
Data Analysis
The data obtained from the study were analyzed 
using Statistical Package for Social Sciences (SPSS) 
version 21 (IBM SPSS Inc, USA). Proportions were 
compared using Chi-square with condence limit 
(p-value) of < 0.05 considered signicant.
Consent for publication
All the authors reviewed and gave their approval 
for this article to be submitted for publication.
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RESULTS
Of the overall 300 respondents, 6.3% were culture 
positive for group B Streptococcus (GBS). Out of the 
200 pregnant women recruited for this study, GBS 
was isolated in 6.5% of the participants while 6.0% 
of the 100 non-pregnant women enrolled were 
cultured positive for GBS colonization. However, 
the difference in colonization rate between the 
pregnant and non-pregnant women was not 
2 
statistically signicant (X = 0.028, p = 0.867) (Table 1).
The association between GBS colonization rate 
and gestational age is summarized in Table 2. 
None of the respondents was found to be 
colonized by GBS in rst trimester. The rate of 
colonization in second trimester was 8.9%. In third 
trimester, the colonization rate dropped slightly to 
5.2%. The colonization rate based on gestational 
2 
age was not statistically signicant (X = 1.453, p = 
0.484) (Table 2).
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In addition, GBS colonization did not appear to be 
inuenced by maternal age. The study revealed a 
higher colonization rate of 11.1% in pregnant 
women among the age group 16-20 years and 
lower rate of 2.2% in age group 36-40 years. For the 
non-pregnant women, the colonization rate was 
observed to be highest in the age group 21-25 years 
(18.2%) followed by the age group 36-40 years 
(11.8%). GBS was not isolated from the age group 
16-20 years and from those ≥40 years among non-
pregnant women.
In the overall population, GBS colonization was 
highest among the age group 21-25 years (11.9%) 
with lowest rate of 3.6% among age group ≥40 
years. The age groups 16-20 years and 26-30 years 
had colonization rate of  6 .3% and 6.8% 
respectively. Nevertheless, the colonization rate 
between the age groups was not statistically 
2 
signicant (X = 2.780, p = 0.734) (Table 3). 
Table 4 summarized the prevalence of GBS 
colonization in relation to social demographic 
factors. On the basis of marital status, pregnant 
women in a polygamy setting had the highest 
colonization rate of 7.4% followed by those that 
were single 7.1%, while monogamy had carriage 
rate of 6.3%. In non-pregnant women, polygamy 
carriage rate was 7.1%. Rate of 6.7% and 5.6% were 
recorded for singles and monogamy respectively. 
2 
The rate was not inuence by marital status (X = 
0.377, p = 0.828).
Educational level seemed to have signicant 
inuence on the occurrence of GBS. Among the 
pregnant group, those that had non-formal 
education had the highest carriage rate of 33.3% 
while 28.6% were obtained from the non-pregnant 
population. Those with tertiary education 
recorded a carriage rate of 6.6% among pregnant 
women while secondary level had the least 3.3%. 
In non-pregnant women, the second highest rate 
of occurrence of 9.5% was observed among those 
with primary education. These values were 
2 statistically signicant (X = 22.427, p = 0.0001).
Religion had no statistical signicant on the 
carriage rate of GBS. The Christian population 
among pregnant women had a colonization rate of 
5.1% while the Muslims recorded 9.7%. In non-
pregnant women, the rate was 4.8% and 8.1% for 
Christians and Muslims respectively.
Another social demographic factor that had 
s ignicant  s ta t i s t i ca l  d i f ference  on the 
colonization rate of GBS was the use of antibiotics. 
It was observed during this study that pregnant 
women on antibiotics had a carriage rate of 12.5% 
and a lower rate of 3.7% among pregnant women 
not on antibiotics. The colonization rate was also 
higher among antibiotics exposed non-pregnant 
participants (33.3%).The inuence of antibiotics 
on GBS colonization rate among the study 
2population was statistically signicant (X  = 3.889,  
p = 0.049).
On the basis of co-morbidity, it was observed that 
diabetic patients had colonization rate of 33.3% 
among pregnant and non-pregnant women. 
Among pregnant women, those without diabetic 
recorded a colonization rate of 6.1% while 5.2% 
was observed among non-pregnant population. 
2These values were statistically signicant (X  = 
7.524, p = 0.006). 
Antibiotic susceptibility testing revealed that all 
the isolates were susceptible to penicillin, 
erythromycin and clindamycin. 94.7% of the 
isolates were sensitive to ampicillin while 5.3% 
where resistant. Ceftriaxone had sensitivity of 
89.5% with 10.5% of the isolates resistant to 
ceftriaxone. 21.1% of the isolates demonstrated 
resistant to vancomycin. 
This sensitivity pattern shows that penicillin is the 
drug of choice for intrapartum prophylaxis while, 
erythromycin and clindamycin can be used in the 
case of penicillin allergy (Table 5).
Table 1: Group B Streptococcal carriage rates 
among pregnant and non-pregnant women in 

























Total 300 19 6.3 
p >0.05 p = 0.867χ2 = 0.028df = 1  
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Table 2: GBS colonization rate in relation to gestational age in HIV positive and HIV negative 
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Third trimester   
 
56                       3(5.4)  
 
59                     3(5.1)  
 
6(5.2)  
Total  100                     8(8.0)  100                   5(5.0)  13(6.5%)  
P = 0.484  χ2 = 1.453  df = 2  
Table 3: Carriage of Streptococcus agalactiae among pregnant and non-pregnant women in Jos 




          
Pregnant
 
No. Tested    No. Positive(%)
 
         
Non-Pregnant
 















7                           0(0.0)                           
 
 
     




31                          3(9.7)                         11                        2(18.2)                              5(11.9)                             
26-30  
 
59                          4(6.8)                       15                       1(6.7)                        5(6.8)                            
31-35  
 
45                         3(6.7)                     32                       1(3.1)                          4(5.2)                           
36-40  
 
46                        1(2.2)                    17                       2(11.8)                          3(4.8)                         
=40   
 
10                        1(10.0)                  18                        0(0.0)                        1(3.6)                       
Total  200                    13(6.5)                          100                    6(6.0)                  19(6.3)                        
 P = 0.734  χ2 = 2.780  df = 5  
Table 4: Group B streptococci carriage rates among pregnant and non-pregnant women in Jos 
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22.427, p = 0.0001, df =3























χ2 = 1.894  p =  0.169  df = 1
   
Occupation
   
Civil servant 








Housewife 78 5(6.4) 37 2(5.4) 7(6.1)
Business 69 5(7.2) 28 3(10.7) 8(8.2)
χ2 = 1.085 p = 1.581  df= 2
     
Miscarriage 
     
None 131 6(4.6) 62 3(4.8) 9(4.7)
Yes 69 7(10.1) 38 3(7.9) 10(9.3)
χ2 = 2.5333 p = 0.1107  df = 1
No. Sexual  Partners
One partner 189 12(6.3) 94 6(6.4) 18(6.4)
Multiple 11 1(9.1) 6 0(0.0) 1(5.9)
χ2 = 0.006 p  = 0.937  df=1
Douching
Yes                                  74                         5(6.8)                                          30 2(6.7) 7(6.7)
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Table 5: Antibiotics sensitivity proles of 
Streptococcus agalactiae isolates from HIV-
positive and HIV-negative women
The variations between countries could possibly 
be due to differences in sampling and culturing 
techniques, types of media used as well as the 
34
population studied . For instance, in this study, 
samples were collected from pregnant women 
regardless of gestational age unlike most other 
studies that recruited pregnant women at 35-
37weeks of gestation.
Majority of the subjects recruited in this study 
were between the ages of 26-30 years. This age 
range corresponds to the reproductive age period 
35,4
of most women in developing countries . This 
study revealed that the age group 21-25 years was 
associated with the highest colonization rate of 
GBS and decreases with advanced age, though, 
not statistically signicant. This is a sexually active 
group and it has been stated that vaginal 
colonization by GBS is associated with sexual 
4
intercourse . These ndings correlated with the 
36report of Ezeonu et al (2012)  in Enugu that GBS 
carriage rate was highest in women between age 
group 21-25 years. This is also similar to the report 
37 38
of Dzowela et al (2005)  and Lekala et al (2015)  but 
in contrast with some other reports that stated that 
colonization rate increases with advanced 
39,24maternal age
Generally, GBS colonization did not appeared to 
be inuenced by gestational age since there was no 
statistical association between the gestational age 
and colonization rate. This study indicated that 
women were more colonized in the second 
trimester than the third trimester. This is 
40
consistent with the report of Donbraye et al (2010)  
in Ibadan and in contrast with the observation of 
Joachim et al (2009), and Okon et al (2013) in North-
eastern Nigeria that colonization rate is more in 
28,25third trimester . Group B Streptococcus was not 
isolated from women in their rst trimester which 
41correlated with the report of Raj et al (2009)  that 
colonization varied signicantly with gestational 
age and that screening of women six weeks before 
delivery may not predict vaginal colonization and 
outcome at birth.
There was a varied association between social 
demographic factors and GBS colonization. It was 
observed that GBS colonization was signicantly 
inuenced by educational level, antibiotics used, 
and diabetes. Those with non-formal education 
were noted to have the highest colonization rate of 
6(31.6%). This nding is similar to the report of 
 Antibiotic     % Sensitive                  % Resistant  
 Penicillin  G        100.0                        0.0  
 Ampicillin            94.7                       5.3   
Vancomycin   
 
        78.9 
 





      100.0 
 
                       0.0 
 
 
Clindamycin   
 
      100.0 
 
                       0.0 
 
 
Ceftriaxone   
 
        89.5 
 




An overall GBS colonization rate of 6.3% was 
observed in this study population. The carriage 
rate was 6.5% in pregnant women and 6.0% in non-
pregnant women. This result is lower than the 
7.0% previously reported by Nsagha et al (1997) in 
21
Jos . The slight decrease in the colonization rate 
may be attributed to improve health awareness 
among the general public and also improvement 
in culturing technique as Todd-Hewitt broth and 
chromatic Strepto B agar which are selective 
media for Streptococcus agalactiae were used in this 
study making identication and differentiation 
easy rather than just blood agar.
In other parts of Nigeria, 19.0% was reported in 
22 23
Ibadan by Onile (1990)  and Uhiara (1993)  
reported a carriage rate of 9.0% in Calaber. 
Onipede and his colleagues in 2012 reported a 
higher prevalence rate of 11.3% in Ile-Ife while 
9.8% was reported by Okon et al 2013 in North-
24,25
eastern Nigeria .The colonization rate observed 
in this study was also lower than reported rates 
f r o m  s e v e r a l  o t h e r  A f r i c a n  c o u n t r i e s . 
Approximately 31.6% was reported in Zimbabwe 
26
by Moyoet al (2000) , 25.3% in Egypt by Shabayek 
27 28et al (2014)  and 23% in Tanzania .
When compared with studies conducted in some 
developed countries, it was observed that the 
result of this study was lower to what was 
29obtained in United States of America . Tor-Udom 
30et al (2006)  reported a carriage rate of 16.0% in 
31
Thailand while 24.0% was reported in Belgium . A 
similar study conducted in Poland by Brzychczy-
32
Wloch et al (2013)  reported 29.5% carriage rate. 
These results are higher to 5.7% obtained in 
33Israel .
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5Regan et al (1996)  that colonization rate was 
higher in women with low social status and 
25education level but contrary to Okon et al (2013)  
report that women with non-formal education had 
lower carriage rate. Participants with tertiary had 
the second highest carriage rate but this may be 
due to the fact that majority of the recruited 
participants were from this group. These nding 
were statistically signicant (p < 0.05).
Another important social demographic factor that 
inuenced the carriage rate of GBS in pregnancy 
was co-morbidity with diabetes. It was observed 
that those who were diabetic had a carriage rate of 
33.3% and the value was statistically signicant as 
p-value was <0.05. This may be due to the fact that 
diabetes is an immunosuppressive disease 
resulting in increased risk of infection even by 
normal ora.
The use of antibiotics in pregnancy and GBS 
colonization was found to be statistically 
signicant. This is probably signicant because 
only few subjects recruited were on antibiotics. 
The 2(17.6%) isolates that were resistant to 
ceftriaxone were isolated from patients on 
antibiotics. This may possibly be due to 
indiscriminate used of the antibiotic in pregnancy 
to treat other infection making the organism to 
develop resistant.
In this study, maternal colonization rate was seen 
more among the primigravida (8.1%) and 
grandmult igravida (7 .6%) and lower in 
nulliparous women. This observation is similar to 
42
the report of Yow et al (1979)  but in contrast with 
43the ndings of Baker et al (1976) . It is also 
suggested that this greater GBS colonization often 
o b s e r v e d  a m o n g  p r i m i g r a v i d a  a n d 
grandmul t iparous  has  ep idemio log ica l 
implications in term of maternal complications 
and neonatal infections and policy issues in 
34
introducing preventive interventions .
Antibiotic susceptibility testing was performed on 
all the isolates to determine the sensitivity pattern. 
The isolates showed 100% sensitivity to penicillin 
G, erythromycin and clindamycin. Though 
ampicillin has been preferred by numerous 
investigators as a drug of choice because it is safe 
and has a broader spectrum than penicillin G, 5.3% 
of the isolates were resistant to ampicillin. About 
21.1% and 10.5% demonstrated resistant to 
vancomycin and ceftriaxone respectively. 
Erythromycin and clindamycin is usually the 
preferred antibiotic in penicillin allergy but 
resistant to this antibiotic has been reported in 
some countries. In Canada, erythromycin and 
clindamycin resistant rates were found to be 17 
44and 8% respectively . This is similar to a 
Tanzanian study that reported a GBS resistance 
rate of 17.4 and 13% for erythromycin and 
clindamycin respectively and 21% erythromycin 
3 9 , 2 8
resistant in Malawi . This suggests that 
antibiotic resistance in GBS may be similar despite 
different geographic locations in sub-Saharan 
Africa. However, phylogenetic studies are 
necessary to verify this. 
CONCLUSION
This study showed that GBS colonization rate 
among the study populat ion was 6 .3%. 
Approximately, 6.5% and 6.0% prevalence rate 
was found among pregnant and non-pregnant 
women respectively. All the isolates were 
sensitive to penicillin, erythromycin and 
clindamycin. A total of 21.5% of the isolates were 
resistant to vancomycin. Ceftriaxone and 
ampicillin resistant was demonstrated in 10.5% 
and 5.3% respectively. 
RECOMMENDATIONS
The high colonization rate of GBS in pregnancy is a 
potential risk for preterm delivery, low-birth 
weight, still birth and neonatal infections. There is 
need for a national policy and guideline for 
screening of pregnant women at 35-37weeks of 
gestation as recommended by the CDC. 
Antibiotics susceptibility testing should also be 
done on all GBS isolates to determine their 
sensitivity pattern in order to guide the choice of 
intrapartum prophylaxis. Penicillin could be a 
drug of choice for intrapartum empirical 
prophylaxis in JUTH while erythromycin and 
clindamycin could be alternative options in 
pregnant women who are allergic to penicillin. 
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